{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:15:20Z","timestamp":1790306120108,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A number of different B cell subsets have been shown to exhibit regulatory activity using a variety of mechanisms to attenuate inflammatory diseases. Here we show, using anti-CD20-mediated partial B cell depletion in mice, that a population of mature B cells distinguishable by IgD<jats:sup>low\/-<\/jats:sup>expression maintains tolerance by, at least in part, promoting CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup>regulatory T cell homeostatic expansion via glucocorticoid-induced tumor necrosis factor receptor ligand, or GITRL. Cell surface phenotyping, transcriptome analysis and developmental study data show that B cells expressing IgD at a low level (BD<jats:sub>L<\/jats:sub>) are a novel population of mature B cells that emerge in the spleen from the transitional-2 stage paralleling the differentiation of follicular B cells. The cell surface phenotype and regulatory function of BD<jats:sub>L<\/jats:sub>are highly suggestive that they are a new B cell subset. Human splenic and peripheral blood IgD<jats:sup>low\/-<\/jats:sup>B cells also exhibit BD<jats:sub>L<\/jats:sub>regulatory activity, rendering them of therapeutic interest.<\/jats:p>","DOI":"10.1038\/s41467-018-08122-9","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:16:42Z","timestamp":1546971402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mature IgDlow\/- B cells maintain tolerance by promoting regulatory T cell homeostasis"],"prefix":"10.1038","volume":"10","author":[{"given":"Avijit","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirthi L.","family":"Pulakanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Gurski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemanti","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-9541","authenticated-orcid":false,"given":"Sridhar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-2457","authenticated-orcid":false,"given":"Bonnie N.","family":"Dittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"8122_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","volume":"184","author":"SD Wolf","year":"1996","unstructured":"Wolf, S. D., Dittel, B. N., Hardardottir, F. & Janeway, C. A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184, 2271\u20132278 (1996).","journal-title":"J. Exp. Med."},{"key":"8122_CR2","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","volume":"178","author":"MK Mann","year":"2007","unstructured":"Mann, M. K., Maresz, K., Shriver, L. P., Tan, Y. & Dittel, B. N. B cell regulation of CD4+CD25+T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178, 3447\u20133456 (2007).","journal-title":"J. Immunol."},{"key":"8122_CR3","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.4049\/jimmunol.1103354","volume":"188","author":"A Ray","year":"2012","unstructured":"Ray, A., Basu, S., Williams, C. B., Salzman, N. H. & Dittel, B. N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188, 3188\u20133198 (2012).","journal-title":"J. Immunol."},{"key":"8122_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944\u2013950 (2002).","journal-title":"Nat. Immunol."},{"key":"8122_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","volume":"194","author":"TF Tedder","year":"2015","unstructured":"Tedder, T. F. B10 cells: a functionally defined regulatory B cell subset. J. Immunol. 194, 1395\u20131401 (2015).","journal-title":"J. Immunol."},{"key":"8122_CR6","doi-asserted-by":"publisher","unstructured":"Ray, A. & Dittel, B. N. Mechanisms of regulatory B cell function in autoimmune and inflammatory diseases beyond IL-10. J. Clin. Med. 6, https:\/\/doi.org\/10.3390\/jcm6010012 (2017).","DOI":"10.3390\/jcm6010012"},{"key":"8122_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2010.10.037","volume":"230","author":"A Ray","year":"2010","unstructured":"Ray, A., Mann, M. K., Basu, S. & Dittel, B. N. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 230, 1\u20139 (2010).","journal-title":"J. Neuroimmunol."},{"key":"8122_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","volume":"127","author":"C Mauri","year":"2017","unstructured":"Mauri, C. & Menon, M. Human regulatory B cells in health and disease: therapeutic potential. J. Clin. Invest. 127, 772\u2013779 (2017).","journal-title":"J. Clin. Invest."},{"key":"8122_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky, A. Y. Regulatory T cells and Foxp3. Immunol. Rev. 241, 260\u2013268 (2011).","journal-title":"Immunol. Rev."},{"key":"8122_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/intimm\/dxq001","volume":"22","author":"G Liao","year":"2010","unstructured":"Liao, G. et al. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+regulatory T cells. Int. Immunol. 22, 259\u2013270 (2010).","journal-title":"Int. Immunol."},{"key":"8122_CR11","doi-asserted-by":"publisher","unstructured":"Ronchetti, S. et al. Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells. J. Immunol. Res. 2015, https:\/\/doi.org\/10.1155\/2015\/171520 (2015).","DOI":"10.1155\/2015\/171520"},{"key":"8122_CR12","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1182\/blood-2010-06-293324","volume":"117","author":"AH Zhang","year":"2011","unstructured":"Zhang, A. H., Skupsky, J. & Scott, D. W. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice. Blood 117, 2223\u20132226 (2011).","journal-title":"Blood"},{"key":"8122_CR13","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.4049\/jimmunol.167.12.6834","volume":"167","author":"D Allman","year":"2001","unstructured":"Allman, D. et al. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167, 6834\u20136840 (2001).","journal-title":"J. Immunol."},{"key":"8122_CR14","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.4049\/jimmunol.1102195","volume":"187","author":"S Basu","year":"2011","unstructured":"Basu, S., Ray, A. & Dittel, B. N. Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses. J. Immunol. 187, 5720\u20135732 (2011).","journal-title":"J. Immunol."},{"key":"8122_CR15","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1002\/eji.200425402","volume":"34","author":"W Seidel-Guyenot","year":"2004","unstructured":"Seidel-Guyenot, W., Alt, R., Perschon, S., Knop, J. & Steinbrink, K. B cells are not required for T cell priming in low zone tolerance to contact allergens and contact hypersensitivity. Eur. J. Immunol. 34, 3082\u20133090 (2004).","journal-title":"Eur. J. Immunol."},{"key":"8122_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","volume":"18","author":"T Saito","year":"2003","unstructured":"Saito, T. et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675\u2013685 (2003).","journal-title":"Immunity"},{"key":"8122_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","volume":"20","author":"D Allman","year":"2008","unstructured":"Allman, D. & Pillai, S. Peripheral B cell subsets. Curr. Opin. Immunol. 20, 149\u2013157 (2008).","journal-title":"Curr. Opin. Immunol."},{"key":"8122_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20071088","volume":"205","author":"A Meyer-Bahlburg","year":"2008","unstructured":"Meyer-Bahlburg, A., Andrews, S. F., Yu, K. O., Porcelli, S. A. & Rawlings, D. J. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 205, 155\u2013168 (2008).","journal-title":"J. Exp. Med."},{"key":"8122_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001\u20131010 (2012).","journal-title":"J. Exp. Med."},{"key":"8122_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1084\/jem.190.1.75","volume":"190","author":"F Loder","year":"1999","unstructured":"Loder, F. et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190, 75\u201389 (1999).","journal-title":"J. Exp. Med."},{"key":"8122_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1084\/jem.20051038","volume":"202","author":"B Srivastava","year":"2005","unstructured":"Srivastava, B., Quinn, W. J. III, Hazard, K., Erikson, J. & Allman, D. Characterization of marginal zone B cell precursors. J. Exp. Med. 202, 1225\u20131234 (2005).","journal-title":"J. Exp. Med."},{"key":"8122_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02684008","volume":"51","author":"RJ Mayer","year":"2002","unstructured":"Mayer, R. J. et al. CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids. Inflamm. Res. 51, 85\u201390 (2002).","journal-title":"Inflamm. Res."},{"key":"8122_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2005.02.006","volume":"17","author":"RT Woodland","year":"2005","unstructured":"Woodland, R. T. & Schmidt, M. R. Homeostatic proliferation of B cells. Semin. Immunol. 17, 209\u2013217 (2005).","journal-title":"Semin. Immunol."},{"key":"8122_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/251550a0","volume":"251","author":"SI Katz","year":"1974","unstructured":"Katz, S. I., Parker, D. & Turk, J. L. B-cell suppression of delayed hypersensitivity reactions. Nature 251, 550\u2013551 (1974).","journal-title":"Nature"},{"key":"8122_CR25","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.4049\/jimmunol.112.5.1826","volume":"112","author":"RM Gorczynski","year":"1974","unstructured":"Gorczynski, R. M. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals. J. Immunol. 112, 1826\u20131838 (1974).","journal-title":"J. Immunol."},{"key":"8122_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/249043a0","volume":"249","author":"AS Russell","year":"1974","unstructured":"Russell, A. S., Liburd, E. M. & Diener, E. In vitro suppression of cell mediated autoimmunity in NZB mice. Nature 249, 43\u201345 (1974).","journal-title":"Nature"},{"key":"8122_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/intimm\/12.5.597","volume":"12","author":"E Mizoguchi","year":"2000","unstructured":"Mizoguchi, E., Mizoguchi, A., Preffer, F. I. & Bhan, A. K. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12, 597\u2013605 (2000).","journal-title":"Int. Immunol."},{"key":"8122_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","volume":"16","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219\u2013230 (2002).","journal-title":"Immunity"},{"key":"8122_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221\u2013241 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"8122_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"8122_CR31","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/eji.201343822","volume":"44","author":"G Heine","year":"2014","unstructured":"Heine, G. et al. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur. J. Immunol. 44, 1615\u20131621 (2014).","journal-title":"Eur. J. Immunol."},{"key":"8122_CR32","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1002\/eji.200636483","volume":"37","author":"TA Barr","year":"2007","unstructured":"Barr, T. A., Brown, S., Ryan, G., Zhao, J. & Gray, D. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37, 3040\u20133053 (2007).","journal-title":"Eur. J. Immunol."},{"key":"8122_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2018.06.007","volume":"49","author":"AC Lino","year":"2018","unstructured":"Lino, A. C. et al. LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity 49, 120\u2013133 e129 (2018).","journal-title":"Immunity"},{"key":"8122_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair, P. A. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129\u2013140 (2010).","journal-title":"Immunity"},{"key":"8122_CR35","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.4049\/jimmunol.162.11.6392","volume":"162","author":"BN Dittel","year":"1999","unstructured":"Dittel, B. N., Merchant, R. M. & Janeway, C. A. Jr. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162, 6392\u20136400 (1999).","journal-title":"J. Immunol."},{"key":"8122_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","volume":"6","author":"MD Pescovitz","year":"2006","unstructured":"Pescovitz, M. D Rituximab an anti-cd20 monoclonal antibody: history and mechanism of action. Am. J. Transplant. 6, 859\u2013866 (2006).","journal-title":"Am. J. Transplant."},{"key":"8122_CR37","doi-asserted-by":"crossref","unstructured":"Clark, E. A. & Ledbetter, J. A. How does B cell depletion therapy work, and how can it be improved?. Ann. Rheum. Dis. 64(Suppl. 4), iv77\u2013iv80 (2005).","DOI":"10.1136\/ard.2005.042507"},{"key":"8122_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner, G. J. Rituximab: mechanism of action. Semin. Hematol. 47, 115\u2013123 (2010).","journal-title":"Semin. Hematol."},{"key":"8122_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","volume":"268","author":"P Bruhns","year":"2015","unstructured":"Bruhns, P. & Jonsson, F. Mouse and human FcR effector functions. Immunol. Rev. 268, 25\u201351 (2015).","journal-title":"Immunol. Rev."},{"key":"8122_CR40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2567.2006.02386.x","volume":"118","author":"R Geisberger","year":"2006","unstructured":"Geisberger, R., Lamers, M. & Achatz, G. The riddle of the dual expression of IgM and IgD. Immunology 118, 429\u2013437 (2006).","journal-title":"Immunology"},{"key":"8122_CR41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4049\/jimmunol.1302848","volume":"193","author":"JM Lykken","year":"2014","unstructured":"Lykken, J. M. et al. Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice. J. Immunol. 193, 746\u2013756 (2014).","journal-title":"J. Immunol."},{"key":"8122_CR42","doi-asserted-by":"publisher","first-page":"12151","DOI":"10.1073\/pnas.1407370111","volume":"111","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi, M. et al. Functional B-1 progenitor cells are present in the hematopoietic stem cell-deficient embryo and depend on Cbfbeta for their development. Proc. Natl Acad. Sci. USA 111, 12151\u201312156 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8122_CR43","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1073\/pnas.1121632109","volume":"109","author":"EE Ghosn","year":"2012","unstructured":"Ghosn, E. E. et al. Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc. Natl Acad. Sci. USA 109, 5394\u20135398 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8122_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/cmi.2012.63","volume":"10","author":"X Zhang","year":"2013","unstructured":"Zhang, X. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10, 113\u2013121 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"8122_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/nyas.12799","volume":"1362","author":"HP Savage","year":"2015","unstructured":"Savage, H. P. & Baumgarth, N. Characteristics of natural antibody-secreting cells. Ann. NY Acad. Sci. 1362, 132\u2013142 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"8122_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2014.00535","volume":"5","author":"AF Cunningham","year":"2014","unstructured":"Cunningham, A. F. et al. B1b cells recognize protective antigens after natural infection and vaccination. Front. Immunol. 5, 535 (2014).","journal-title":"Front. Immunol."},{"key":"8122_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","volume":"23","author":"S Pillai","year":"2005","unstructured":"Pillai, S., Cariappa, A. & Moran, S. T. Marginal zone B cells. Annu. Rev. Immunol. 23, 161\u2013196 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"8122_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12396","volume":"270","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Garcia-Ibanez, L. & Toellner, K. M. Regulation of germinal center B-cell differentiation. Immunol. Rev. 270, 8\u201319 (2016).","journal-title":"Immunol. Rev."},{"key":"8122_CR49","doi-asserted-by":"publisher","unstructured":"Moore, T. C., Gonzaga, L. M., Mather, J. M., Messer, R. J. & Hasenkrug, K. J. B cell requirement for robust regulatory T cell responses to friend retrovirus infection. mBio 8, https:\/\/doi.org\/10.1128\/mBio.01122-17 (2017).","DOI":"10.1128\/mBio.01122-17"},{"key":"8122_CR50","first-page":"73","volume":"22","author":"B Arellano","year":"2016","unstructured":"Arellano, B., Graber, D. J. & Sentman, C. L. Regulatory T cell-based therapies for autoimmunity. Discov. Med. 22, 73\u201380 (2016).","journal-title":"Discov. Med."},{"key":"8122_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxw025","volume":"28","author":"Y Takeuchi","year":"2016","unstructured":"Takeuchi, Y. & Nishikawa, H. Roles of regulatory T cells in cancer immunity. Int. Immunol. 28, 401\u2013409 (2016).","journal-title":"Int. Immunol."},{"key":"8122_CR52","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/WNL.0b013e3181e24373","volume":"74","author":"RT Naismith","year":"2010","unstructured":"Naismith, R. T. et al. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology 74, 1860\u20131867 (2010).","journal-title":"Neurology"},{"key":"8122_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.21363","volume":"63","author":"A Bar-Or","year":"2008","unstructured":"Bar-Or, A. et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 63, 395\u2013400 (2008).","journal-title":"Ann. Neurol."},{"key":"8122_CR54","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2014-07-588376","volume":"125","author":"TR Tipton","year":"2015","unstructured":"Tipton, T. R. et al. Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies. Blood 125, 1901\u20131909 (2015).","journal-title":"Blood"},{"key":"8122_CR55","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1182\/blood-2010-01-263533","volume":"115","author":"SA Beers","year":"2010","unstructured":"Beers, S. A. et al. Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. Blood 115, 5191\u20135201 (2010).","journal-title":"Blood"},{"key":"8122_CR56","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1182\/blood-2008-04-149161","volume":"112","author":"SA Beers","year":"2008","unstructured":"Beers, S. A. et al. Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood 112, 4170\u20134177 (2008).","journal-title":"Blood"},{"key":"8122_CR57","first-page":"2143","volume":"119","author":"A Ivanov","year":"2009","unstructured":"Ivanov, A. et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J. Clin. Invest. 119, 2143\u20132159 (2009).","journal-title":"J. Clin. Invest."},{"key":"8122_CR58","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1182\/blood-2010-07-296913","volume":"117","author":"W Alduaij","year":"2011","unstructured":"Alduaij, W. et al. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood 117, 4519\u20134529 (2011).","journal-title":"Blood"},{"key":"8122_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3324\/haematol.2008.001628","volume":"95","author":"SH Lim","year":"2010","unstructured":"Lim, S. H. et al. Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 95, 135\u2013143 (2010).","journal-title":"Haematologica"},{"key":"8122_CR60","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.4049\/jimmunol.1000303","volume":"186","author":"L Bologna","year":"2011","unstructured":"Bologna, L. et al. Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab. J. Immunol. 186, 3762\u20133769 (2011).","journal-title":"J. Immunol."},{"key":"8122_CR61","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.4049\/jimmunol.1500153","volume":"195","author":"A Ray","year":"2015","unstructured":"Ray, A. et al. Gut microbial dysbiosis due to Helicobacter drives an increase in marginal zone B cells in the absence of IL-10 signaling in macrophages. J. Immunol. 195, 3071\u20133085 (2015).","journal-title":"J. Immunol."},{"key":"8122_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46\u201353 (2013).","journal-title":"Nat. Biotechnol."},{"key":"8122_CR63","doi-asserted-by":"publisher","first-page":"W83","DOI":"10.1093\/nar\/gkw199","volume":"44","author":"J Reimand","year":"2016","unstructured":"Reimand, J. et al. g:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 44, W83\u2013W89 (2016).","journal-title":"Nucleic Acids Res."},{"key":"8122_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"8122_CR65","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"The Gene Ontology, C.","year":"2017","unstructured":"The Gene Ontology, C. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 45, D331\u2013D338 (2017).","journal-title":"Nucleic Acids Res."},{"key":"8122_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"8122_CR67","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"8122_CR68","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cell.2014.10.026","volume":"159","author":"JJ Thome","year":"2014","unstructured":"Thome, J. J. et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159, 814\u2013828 (2014).","journal-title":"Cell"},{"key":"8122_CR69","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nbt.3942","volume":"35","author":"W Meng","year":"2017","unstructured":"Meng, W. et al. An atlas of B-cell clonal distribution in the human body. Nat. Biotechnol. 35, 879\u2013884 (2017).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08122-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:34:49Z","timestamp":1720906489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8122"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-08122-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}